The genes we’re dealt
By Erik Parens,
Aeon
| 11. 10. 2020
Over the past decade, economists, sociologists and psychologists have begun collaborating with geneticists to investigate how genomic differences among human beings are linked to differences in their behaviours and social outcomes. The insights sought are wide-ranging: why do some of us have a greater sense of subjective wellbeing than others? Why do some go further in school than others? When it comes to income, why do some people earn more and others less?
As surprising as it might be to readers familiar with the history of often-ugly efforts to investigate complex behaviours and outcomes through genetics, some prominent members of this new cohort of researchers are optimistic that their work will advance progressive political agendas. According to the progressive authors of a recent European Commission report, insights from what I call ‘social genomics’ are ‘fully compatible with agendas that aim to combat inequalities and that embrace diversity.’
Indeed, findings from social genomics are compatible with what we in the United States consider Left-leaning agendas to combat inequalities. They are, however, equally compatible with what we think of as Right-leaning...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...